Theravance Biopharma, Inc. (FRA:0TB)
Germany · Delayed Price · Currency is EUR 15.30
+0.20 (1.32%)
At close: Dec 19, 2025
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of €812.55 million as of December 22, 2025. Its market cap has increased by 81.45% in one year.
Market Cap
812.55M
Enterprise Value
566.68M
Revenue
68.46M
Ranking
n/a
PE Ratio
32.49
Stock Price
€15.30
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has increased from 16.00 to 812.55M, an increase of 5,078,449,838.91%. That is a compound annual growth rate of 361.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 812.55M | 81.80% |
| Dec 31, 2024 | 446.95M | -11.74% |
| Dec 29, 2023 | 506.39M | -28.28% |
| Dec 30, 2022 | 706.03M | -1.40% |
| Dec 31, 2021 | 716.07M | -22.96% |
| Dec 31, 2020 | 929.45M | -29.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |